Stay updated on Efgartigimod SC in Bullous Pemphigoid: Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page.

Latest updates to the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedRemoved the 403 Forbidden page content and the Home link from the page. The study details page now loads instead of displaying an error.SummaryDifference0.5%

- Check24 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, indicating the record is currently inaccessible and users cannot view the study information or related data.SummaryDifference18%

- Check31 days agoChange DetectedRevision tag changed from v3.6.6 to v3.7.0, indicating the page is rendered with a newer template/version. This update affects the underlying rendering rather than the study content or visible details.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page version tag was updated from Revision: v3.6.5 to Revision: v3.6.6. This indicates a backend/template update without changes to the study content.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a small update to the page's history.SummaryDifference0.0%

Stay in the know with updates to Efgartigimod SC in Bullous Pemphigoid: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page.